HOME >> BIOLOGY >> NEWS
Stanford launches public lecture series on genomic medicine

Stanford University is offering a series of free monthly lectures designed to enhance public understanding of the Human Genome Project and the revolution in genomic medicine. The lecture series, titled ''Sequencing the Human Genome: What Does It Tell Us About Ourselves,'' will be held in Fairchild Auditorium on the Stanford campus.

The first lecture, "Biomedical Innovations: Confronting the Polity," will be presented by Nobel laureate Paul Berg on Monday, Jan. 26, at 6 p.m. PST. Refreshments will be served at 5 p.m.

Berg, the Robert W. and Vivian K. Cahill Professor of Cancer Research, Emeritus, at Stanford, is a pioneer in the field of genetic engineering. He will be introduced by former U.S. Secretary of State George Shultz, the Thomas W. and Susan B. Ford Distinguished Fellow at the Hoover Institution. A 10-minute question-and-answer period will follow Berg's lecture.

The second lecture, focusing on stem cell research, will take place on Friday, Feb. 20, at 4 p.m., following a 3 p.m. reception. The lecture will be presented by stem cell researcher Dr. Irving Weissman, the Karel and Avice Beekhuis Professor of Cancer Biology at Stanford. He will be introduced by Dr. Philip Pizzo, dean of the Stanford School of Medicine.

The third lecture, on genomics and race, will be held on Wednesday, March 17, at 6 p.m., following a reception at 5 p.m. The lecture will be delivered by Stanford geneticist Marcus Feldman, the Burnet C. and Mildred Finley Wohlford Professor in the School of Humanities and Sciences. Feldman will be introduced by Paul Ehrlich, the Bing Professor of Population Studies in the Stanford Department of Biological Sciences and author of Human Natures: Genes, Culture and the Human Prospect. Lectures on other topics also are planned for April and May.

Communicating science

The Genomic Medicine Public Lecture Series was the brainchild of Renu Heller, a former scientist at Stanford and senior scientist wit
'"/>

Contact: Renu Heller
rheller@stanford.edu
650-327-4528
Stanford University
20-Jan-2004


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2019)... ... August 29, 2019 , ... Advancements ... robotics platform in an upcoming episode, which is scheduled to broadcast 1Q/2020. Check ... and commercialization of cost-effective robotic surgical solutions for the treatment of patients suffering ...
(Date:8/27/2019)... (PRWEB) , ... August 26, 2019 , ... Shoreline ... to the strain level, has hired Bill McKenzie as its CEO and Karen Woodward ... to help Shoreline Biome meet growing demand for its products and expand the company’s ...
(Date:8/27/2019)... , ... August 27, 2019 , ... ... science and drug development. This episode is scheduled to broadcast 4Q/2019. Check local ... a biopharmaceutical research, development, investment and manufacturing company. The show will highlight how ...
Breaking Biology News(10 mins):
(Date:8/27/2019)... (PRWEB) , ... August 27, 2019 , ... Dr. Kim ... She recently opened North Peninsula Veterinary Surgical Group , a new surgical practice ... there are plans to expand and add more veterinary specialists as the practice grows. ...
(Date:8/23/2019)... ... August 22, 2019 , ... The EnozoPro® converts ordinary tap water into ... and pathogens on hard surfaces including E. Coli, Salmonella, MRSA, Listeria and Legionella. It ... more information, visit the product page at rovingblue.com , ”At Enozo, our mission is ...
(Date:8/14/2019)... COLLEGE, Pa. (PRWEB) , ... August 13, 2019 ... ... in nuclear receptor and in vitro toxicology testing solutions, announced the appointment of ... healthcare industry experience to the Board. , Mark McLoughlin will lend his healthcare ...
(Date:8/7/2019)... SOLON, Ohio (PRWEB) , ... August 07, 2019 , ... ... with a breakthrough line of soil amendments (soil “probiotics”), including Rhizolizer ® , ... within a year—the largest impact any approach has offered to date. Results from the ...
Breaking Biology Technology:
Cached News: